BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gollin SM. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease. Genes Chromosomes Cancer 2014;53:972-90. [PMID: 25183546 DOI: 10.1002/gcc.22214] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Gołąbek K, Rączka G, Gaździcka J, Miśkiewicz-Orczyk K, Zięba N, Krakowczyk Ł, Misiołek M, Strzelczyk JK. Expression Profiles of CDKN2A, MDM2, E2F2 and LTF Genes in Oral Squamous Cell Carcinoma. Biomedicines 2022;10. [PMID: 36551770 DOI: 10.3390/biomedicines10123011] [Reference Citation Analysis]
2 Teng Y, Gao L, Loveless R, Rodrigo JP, Strojan P, Willems SM, Nathan CA, Mäkitie AA, Saba NF, Ferlito A. The Hidden Link of Exosomes to Head and Neck Cancer. Cancers (Basel) 2021;13:5802. [PMID: 34830956 DOI: 10.3390/cancers13225802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Routila J, Suvila K, Grénman R, Leivo I, Westermarck J, Ventelä S. Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma. BMC Cancer 2021;21:868. [PMID: 34320941 DOI: 10.1186/s12885-021-08618-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Erkizan HV, Sukhadia S, Natarajan TG, Marino G, Notario V, Lichy JH, Wadleigh RG. Exome sequencing identifies novel somatic variants in African American esophageal squamous cell carcinoma. Sci Rep 2021;11:14814. [PMID: 34285259 DOI: 10.1038/s41598-021-94064-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kaur RP, Izumchenko E, Blakaj DM, Mladkova N, Lechner M, Beaumont TL, Floudas CS, Gallia GL, London NR Jr. The genomics and epigenetics of olfactory neuroblastoma: A systematic review. Laryngoscope Investig Otolaryngol 2021;6:721-8. [PMID: 34401496 DOI: 10.1002/lio2.597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 van Harten AM, Brakenhoff RH. Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications. Cancers (Basel) 2021;13:2774. [PMID: 34204886 DOI: 10.3390/cancers13112774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Papenberg BW, Ingles J, Gao S, Feng J, Allen JL, Markwell SM, Interval ET, Montague PA, Wen S, Weed SA. Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma. Cancer Genet 2021;256-257:136-48. [PMID: 34130230 DOI: 10.1016/j.cancergen.2021.05.011] [Reference Citation Analysis]
8 Parfenova E, Liu KYP, Harrison A, MacAulay C, Guillaud M, Poh CF. An improved algorithm using a Health Canada-approved DNA-image cytometry system for non-invasive screening of high-grade oral lesions. J Oral Pathol Med 2021;50:502-9. [PMID: 33275794 DOI: 10.1111/jop.13149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Zhang J, Zhong X, Jiang H, Jiang H, Xie T, Tian Y, Li R, Wang B, Zhang J, Yuan Y. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma. Aging (Albany NY) 2020;12:22509-26. [PMID: 33216727 DOI: 10.18632/aging.103460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dayer G, Masoom ML, Togtema M, Zehbe I. Virus-Host Protein-Protein Interactions between Human Papillomavirus 16 E6 A1 and D2/D3 Sub-Lineages: Variances and Similarities. Int J Mol Sci 2020;21:E7980. [PMID: 33121134 DOI: 10.3390/ijms21217980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Wang C, Gan N, Liu P, Chen H, Li Y, Li X. Expression and Genetic Polymorphisms of ERCC1 in Chinese Han Patients with Oral Squamous Cell Carcinoma. Biomed Res Int 2020;2020:1207809. [PMID: 33029487 DOI: 10.1155/2020/1207809] [Reference Citation Analysis]
12 Su R, Zhang J, Liu X, Wei L. Identification of expression signatures for non-small-cell lung carcinoma subtype classification. Bioinformatics 2020;36:339-46. [PMID: 31297509 DOI: 10.1093/bioinformatics/btz557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
13 Dayer G, Masoom ML, Togtema M, Zehbe I. Virus-host protein-protein interactions between human papillomavirus 16 E6 A1 and D2/D3 sub-lineages: variances and similarities.. [DOI: 10.1101/2020.06.26.169458] [Reference Citation Analysis]
14 Wachters JE, Kop E, Slagter-Menkema L, Mastik M, van der Wal JE, van der Vegt B, de Bock GH, van der Laan BFAM, Schuuring E. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas. Laryngoscope 2020;130:2825-32. [PMID: 32065407 DOI: 10.1002/lary.28532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Cheng H, Yang X, Si H, Saleh AD, Xiao W, Coupar J, Gollin SM, Ferris RL, Issaeva N, Yarbrough WG, Prince ME, Carey TE, Van Waes C, Chen Z. Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. Cell Rep 2018;25:1332-1345.e5. [PMID: 30380422 DOI: 10.1016/j.celrep.2018.10.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
16 Arenz A, Patze J, Kornmann E, Wilhelm J, Ziemann F, Wagner S, Wittig A, Schoetz U, Engenhart-Cabillic R, Dikomey E, Fritz B. HPV-negative and HPV-positive HNSCC cell lines show similar numerical but different structural chromosomal aberrations. Head Neck 2019;41:3869-79. [PMID: 31441163 DOI: 10.1002/hed.25924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Park SJ, Ye W, Xiao R, Silvin C, Padget M, Hodge JW, Van Waes C, Schmitt NC. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. Oral Oncol 2019;95:127-35. [PMID: 31345380 DOI: 10.1016/j.oraloncology.2019.06.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
18 Tian S, Meng G, Zhang W. A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma. Cancer Manag Res 2019;11:131-42. [PMID: 30588115 DOI: 10.2147/CMAR.S185875] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
19 Strzelczyk JK, Krakowczyk Ł, Owczarek AJ. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma. Arch Oral Biol 2019;98:265-72. [PMID: 30576962 DOI: 10.1016/j.archoralbio.2018.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
20 Wintergerst L, Selmansberger M, Maihoefer C, Schüttrumpf L, Walch A, Wilke C, Pitea A, Woischke C, Baumeister P, Kirchner T, Belka C, Ganswindt U, Zitzelsberger H, Unger K, Hess J. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Mol Oncol 2018;12:2085-101. [PMID: 30259648 DOI: 10.1002/1878-0261.12388] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
21 Pitea A, Kondofersky I, Sass S, Theis FJ, Mueller NS, Unger K. Copy number aberrations from Affymetrix SNP 6.0 genotyping data-how accurate are commonly used prediction approaches? Brief Bioinform 2018. [PMID: 30351397 DOI: 10.1093/bib/bby096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Cadoni G, Giraldi L, Petrelli L, Pandolfini M, Giuliani M, Paludetti G, Pastorino R, Leoncini E, Arzani D, Almadori G, Boccia S. Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy. Acta Otorhinolaryngol Ital 2017;37:458-66. [PMID: 28663597 DOI: 10.14639/0392-100X-1246] [Cited by in Crossref: 45] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
23 Wittekindt C, Wagner S, Sharma SJ, Würdemann N, Knuth J, Reder H, Klußmann JP. [HPV - A different view on Head and Neck Cancer]. Laryngorhinootologie 2018;97:S48-S113. [PMID: 29905354 DOI: 10.1055/s-0043-121596] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
24 Wemmert S, Linxweiler M, Lerner C, Bochen F, Kulas P, Linxweiler J, Smola S, Urbschat S, Wagenpfeil S, Schick B. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations. J Cancer Res Clin Oncol 2018;144:1129-41. [PMID: 29560516 DOI: 10.1007/s00432-018-2629-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Lin CW, Chou YE, Yeh CM, Yang SF, Chuang CY, Liu YF. A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma. Oncotarget 2017;8:34630-42. [PMID: 28423715 DOI: 10.18632/oncotarget.16120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
26 Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget 2016;7:52584-96. [PMID: 27256979 DOI: 10.18632/oncotarget.9683] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
27 D'souza W, Saranath D. OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice. OMICS: A Journal of Integrative Biology 2017;21:689-703. [DOI: 10.1089/omi.2017.0146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Bhosale PG, Pandey M, Cristea S, Shah M, Patil A, Beerenwinkel N, Schäffer AA, Mahimkar MB. Recurring Amplification at 11q22.1-q22.2 Locus Plays an Important Role in Lymph Node Metastasis and Radioresistance in OSCC. Sci Rep 2017;7:16051. [PMID: 29167558 DOI: 10.1038/s41598-017-16247-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
29 Tran L, Allen CT, Xiao R, Moore E, Davis R, Park SJ, Spielbauer K, Van Waes C, Schmitt NC. Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma. Cancer Immunol Res 2017;5:1141-51. [PMID: 29097421 DOI: 10.1158/2326-6066.CIR-17-0235] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 16.3] [Reference Citation Analysis]
30 Ribeiro IP, Barroso L, Marques F, Santos A, Caramelo F, Julião MJ, Melo JB, Carreira IM. Genomic and epigenetic characterization for the comparison of synchronous bilateral tongue squamous cell carcinomas-A case report. Curr Probl Cancer 2017;41:398-406. [PMID: 29056289 DOI: 10.1016/j.currproblcancer.2017.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Guo W, Chen X, Zhu L, Wang Q. A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma. Oncotarget 2017;8:94528-38. [PMID: 29212247 DOI: 10.18632/oncotarget.21786] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
32 Chen X, Song Q, Xia L, Xu X. Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice. Med Sci Monit 2017;23:4471-6. [PMID: 28918429 DOI: 10.12659/msm.905814] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Van Waes C, Musbahi O. Genomics and advances towards precision medicine for head and neck squamous cell carcinoma. Laryngoscope Investig Otolaryngol 2017;2:310-9. [PMID: 29094075 DOI: 10.1002/lio2.86] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
34 Saha SK, Maiti GP, Roychoudhury S, Panda CK. Molecular progression of head and neck squamous cell carcinoma. Nucleus 2017;60:111-119. [DOI: 10.1007/s13237-017-0212-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Wichmann G, Dietz A. [Preclinical models to establish innovative therapy strategies : Ex‑vivo assessment of head and neck tumor chemo- and immune responses]. HNO 2016;64:460-9. [PMID: 27259639 DOI: 10.1007/s00106-016-0160-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Bhosale PG, Cristea S, Ambatipudi S, Desai RS, Kumar R, Patil A, Kane S, Borges AM, Schäffer AA, Beerenwinkel N, Mahimkar MB. Chromosomal Alterations and Gene Expression Changes Associated with the Progression of Leukoplakia to Advanced Gingivobuccal Cancer. Transl Oncol 2017;10:396-409. [PMID: 28433800 DOI: 10.1016/j.tranon.2017.03.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
37 Perri F, Longo F, Giuliano M, Sabbatino F, Favia G, Ionna F, Addeo R, Della Vittoria Scarpati G, Di Lorenzo G, Pisconti S. Epigenetic control of gene expression: Potential implications for cancer treatment. Crit Rev Oncol Hematol 2017;111:166-72. [PMID: 28259291 DOI: 10.1016/j.critrevonc.2017.01.020] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 13.5] [Reference Citation Analysis]
38 Dong TT, Wang LJ, Liu LZ, Ma SN. Susceptibility to oral squamous cell carcinoma: correlation with variants of CYP1A1-MspI, GSTT1, GSTM1, ALDH2, EC-SOD and Lifestyle factors. Balkan J Med Genet 2016;19:61-70. [PMID: 28289590 DOI: 10.1515/bjmg-2016-0037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
39 Pattle SB, Utjesanovic N, Togo A, Wells L, Conn B, Monaghan H, Junor E, Johannessen I, Cuschieri K, Talbot S. Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma: ANO1, MOLECULAR MARKER OF METASTATIC DISEASE. Genes Chromosomes Cancer 2017;56:185-98. [DOI: 10.1002/gcc.22425] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
40 Yalniz Z, Demokan S, Karabulut B, Ulusan M, Suoglu Y, Dalay N. Copy number profiling of tumor suppressor genes in head and neck cancer. Head Neck 2017;39:341-6. [PMID: 27696595 DOI: 10.1002/hed.24593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Kaseb HO, Fohrer-Ting H, Lewis DW, Lagasse E, Gollin SM. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Exp Cell Res 2016;348:75-86. [PMID: 27619333 DOI: 10.1016/j.yexcr.2016.09.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
42 Wagner S, Würdemann N, Hübbers C, Reuschenbach M, Prigge ES, Wichmann G, Hess J, Dietz A, Dürst M, Tinhofer I, von Knebel-Döberitz M, Wittekindt C, Klussmann JP. [HPV-associated head and neck cancer : mutational signature and genomic aberrations]. HNO 2015;63:758-67. [PMID: 26507715 DOI: 10.1007/s00106-015-0074-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
43 William WN Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol 2016;2:209-16. [PMID: 26540028 DOI: 10.1001/jamaoncol.2015.4364] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 12.4] [Reference Citation Analysis]
44 Kaseb HO, Lewis DW, Saunders WS, Gollin SM. Cell division patterns and chromosomal segregation defects in oral cancer stem cells. Genes Chromosomes Cancer 2016;55:694-709. [PMID: 27123539 DOI: 10.1002/gcc.22371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
45 Henrique T, José Freitas da Silveira N, Henrique Cunha Volpato A, Mioto MM, Carolina Buzzo Stefanini A, Bachir Fares A, Gustavo da Silva Castro Andrade J, Masson C, Verónica Mendoza López R, Daumas Nunes F, Paulo Kowalski L, Severino P, Tajara EH. HNdb: an integrated database of gene and protein information on head and neck squamous cell carcinoma. Database (Oxford) 2016;2016:baw026. [PMID: 27013077 DOI: 10.1093/database/baw026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
46 Routila J, Bilgen T, Saramäki O, Grénman R, Visakorpi T, Westermarck J, Ventelä S. Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma. J Oral Pathol Med 2016;45:329-37. [PMID: 26436875 DOI: 10.1111/jop.12372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Wangsa D, Chowdhury SA, Ryott M, Gertz EM, Elmberger G, Auer G, Åvall Lundqvist E, Küffer S, Ströbel P, Schäffer AA, Schwartz R, Munck-Wikland E, Ried T, Heselmeyer-Haddad K. Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis. Int J Cancer 2016;138:98-109. [PMID: 26175310 DOI: 10.1002/ijc.29691] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
48 Zhang Z, Yang XF, Huang KQ, Ren L, Gou WF, Shen DF, Zhao S, Sun HZ, Takano Y, Zheng HC. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas. Tumour Biol 2015;36:9487-97. [PMID: 26124004 DOI: 10.1007/s13277-015-3618-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
49 Kansy BA, Schmitt NC, Ferris RL. Immune Escape and Immunotherapy of HPV-Related Oropharyngeal Cancer: Has the Future Arrived? Curr Otorhinolaryngol Rep 2015;3:63-72. [DOI: 10.1007/s40136-015-0079-8] [Reference Citation Analysis]
50 Raju SC, Hauff SJ, Lemieux AJ, Orosco RK, Gross AM, Nguyen LT, Savariar E, Moss W, Whitney M, Cohen EE, Lippman SM, Tsien RY, Ideker T, Advani SJ, Nguyen QT. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncol 2015;51:470-5. [PMID: 25735654 DOI: 10.1016/j.oraloncology.2015.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
51 Gollin SM. Epidemiology of HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer 2015. [DOI: 10.1007/978-3-319-21100-8_1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]